H. Jang Et Al. , "Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B," Clinical Gastroenterology and Hepatology , vol.74, 2021
Jang, H. Et Al. 2021. Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology , vol.74 .
Jang, H., Yoon, J. S., Park, S. Y., Lee, H. A., Jang, M., Kim, S. U., ... Sinn, D. H.(2021). Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology , vol.74.
Jang, Heejoon Et Al. "Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B," Clinical Gastroenterology and Hepatology , vol.74, 2021
Jang, Heejoon Et Al. "Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B." Clinical Gastroenterology and Hepatology , vol.74, 2021
Jang, H. Et Al. (2021) . "Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B." Clinical Gastroenterology and Hepatology , vol.74.
@article{article, author={Heejoon Jang Et Al. }, title={Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B}, journal={Clinical Gastroenterology and Hepatology}, year=2021}